NEXTCURE, INC Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEXTCURE, INC stock issued during period, value, new issues for the quarter ending 2026-03-31 was $1.23M.
- NEXTCURE, INC stock issued during period, value, new issues for the quarter ending 2024-06-30 was $39.00K.
- NEXTCURE, INC stock issued during period, value, new issues for the quarter ending 2021-03-31 was $63.00K, a 70.27% increase year-over-year.
- NEXTCURE, INC stock issued during period, value, new issues for the quarter ending 2020-09-30 was $54.00K, a 145.45% increase year-over-year.
- NEXTCURE, INC stock issued during period, value, new issues for fiscal 2024 was $39.00K.
- NEXTCURE, INC stock issued during period, value, new issues for fiscal 2020 was $112.00K, a 5.88% decline from fiscal 2019.
- NEXTCURE, INC stock issued during period, value, new issues for fiscal 2019 was $119.00K, a 2875.00% increase from fiscal 2018.
- NEXTCURE, INC stock issued during period, value, new issues for fiscal 2018 was $4.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $1.23M S-4 · filed 2026-08-18 | |
| 2024-12-31 | $39.00K 10-K · filed 2025-03-06 | |
| 2024-06-30 | $39.00K 10-Q · filed 2025-11-05 | |
| 2021-03-31 | $63.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $112.00K 10-K · filed 2021-03-04 | |
| 2020-09-30 | $54.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $3.00K 10-Q · filed 2020-11-05 | |
| 2020-03-31 | $37.00K 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $119.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $22.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $43.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $4.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $4.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |